CLDN6 and breast cancer: The expression of CLDN6 was lower in breast cancer tissues than non–neoplastic tissues based on a GEO dataset analysis and TMA analysis, and its low expression was associated with a poor prognosis, which is in line with the study by Jia et al. [32].